COVID-19 Impact on Coagulation Factors Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Coagulation Factors Industry
1.7 COVID-19 Impact: Coagulation Factors Market Trends
2 Global Coagulation Factors Quarterly Market Size Analysis
2.1 Coagulation Factors Business Impact Assessment - COVID-19
2.1.1 Global Coagulation Factors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Coagulation Factors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Coagulation Factors Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Coagulation Factors Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Coagulation Factors Factory Price by Manufacturers
3.3 Location of Key Manufacturers Coagulation Factors Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Coagulation Factors Market
3.5 Key Manufacturers Coagulation Factors Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Coagulation Factors Segments, By Type
4.1 Introduction
1.4.1 Coagulation Factor VIIa
1.4.2 Coagulation Factor IX
1.4.3 Coagulation Factor IX
1.4.4 Coagulation FactorIX
1.4.5 Coagulation Factor X
1.4.6 Other
4.2 By Type, Global Coagulation Factors Market Size, 2019-2021
4.2.1 By Type, Global Coagulation Factors Market Size by Type, 2020-2021
4.2.2 By Type, Global Coagulation Factors Price, 2020-2021
5 Impact of Covid-19 on Coagulation Factors Segments, By Application
5.1 Overview
5.5.1 Pharmacy
5.5.2 Hospital
5.2 By Application, Global Coagulation Factors Market Size, 2019-2021
5.2.1 By Application, Global Coagulation Factors Market Size by Application, 2019-2021
5.2.2 By Application, Global Coagulation Factors Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Business Overview
7.1.2 Shire (Baxter) Coagulation Factors Quarterly Production and Revenue, 2020
7.1.3 Shire (Baxter) Coagulation Factors Product Introduction
7.1.4 Shire (Baxter) Response to COVID-19 and Related Developments
7.2 Bayer
7.2.1 Bayer Business Overview
7.2.2 Bayer Coagulation Factors Quarterly Production and Revenue, 2020
7.2.3 Bayer Coagulation Factors Product Introduction
7.2.4 Bayer Response to COVID-19 and Related Developments
7.3 CSL
7.3.1 CSL Business Overview
7.3.2 CSL Coagulation Factors Quarterly Production and Revenue, 2020
7.3.3 CSL Coagulation Factors Product Introduction
7.3.4 CSL Response to COVID-19 and Related Developments
7.4 Pfizer
7.4.1 Pfizer Business Overview
7.4.2 Pfizer Coagulation Factors Quarterly Production and Revenue, 2020
7.4.3 Pfizer Coagulation Factors Product Introduction
7.4.4 Pfizer Response to COVID-19 and Related Developments
7.5 Grifols
7.5.1 Grifols Business Overview
7.5.2 Grifols Coagulation Factors Quarterly Production and Revenue, 2020
7.5.3 Grifols Coagulation Factors Product Introduction
7.5.4 Grifols Response to COVID-19 and Related Developments
7.6 Biogen
7.6.1 Biogen Business Overview
7.6.2 Biogen Coagulation Factors Quarterly Production and Revenue, 2020
7.6.3 Biogen Coagulation Factors Product Introduction
7.6.4 Biogen Response to COVID-19 and Related Developments
7.7 Octapharma
7.7.1 Octapharma Business Overview
7.7.2 Octapharma Coagulation Factors Quarterly Production and Revenue, 2020
7.7.3 Octapharma Coagulation Factors Product Introduction
7.7.4 Octapharma Response to COVID-19 and Related Developments
7.8 NovoNordisk
7.8.1 NovoNordisk Business Overview
7.8.2 NovoNordisk Coagulation Factors Quarterly Production and Revenue, 2020
7.8.3 NovoNordisk Coagulation Factors Product Introduction
7.8.4 NovoNordisk Response to COVID-19 and Related Developments
7.9 Greencross
7.9.1 Greencross Business Overview
7.9.2 Greencross Coagulation Factors Quarterly Production and Revenue, 2020
7.9.3 Greencross Coagulation Factors Product Introduction
7.9.4 Greencross Response to COVID-19 and Related Developments
7.10 Kedrion
7.10.1 Kedrion Business Overview
7.10.2 Kedrion Coagulation Factors Quarterly Production and Revenue, 2020
7.10.3 Kedrion Coagulation Factors Product Introduction
7.10.4 Kedrion Response to COVID-19 and Related Developments
7.11 BPL
7.11.1 BPL Business Overview
7.11.2 BPL Coagulation Factors Quarterly Production and Revenue, 2020
7.11.3 BPL Coagulation Factors Product Introduction
7.11.4 BPL Response to COVID-19 and Related Developments
7.12 Hualan Bio
7.12.1 Hualan Bio Business Overview
7.12.2 Hualan Bio Coagulation Factors Quarterly Production and Revenue, 2020
7.12.3 Hualan Bio Coagulation Factors Product Introduction
7.12.4 Hualan Bio Response to COVID-19 and Related Developments
7.13 RAAS
7.13.1 RAAS Business Overview
7.13.2 RAAS Coagulation Factors Quarterly Production and Revenue, 2020
7.13.3 RAAS Coagulation Factors Product Introduction
7.13.4 RAAS Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Coagulation Factors Supply Chain Analysis
8.1.1 Coagulation Factors Supply Chain Analysis
8.1.2 Covid-19 Impact on Coagulation Factors Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Coagulation Factors Distribution Channels
8.2.2 Covid-19 Impact on Coagulation Factors Distribution Channels
8.2.3 Coagulation Factors Distributors
8.3 Coagulation Factors Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Coagulation Factors Assessment
Table 9. COVID-19 Impact: Coagulation Factors Market Trends
Table 10. COVID-19 Impact Global Coagulation Factors Market Size
Table 11. Global Coagulation Factors Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Coagulation Factors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Coagulation Factors Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Coagulation Factors Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Coagulation Factors Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Coagulation Factors Market Growth Drivers
Table 17. Global Coagulation Factors Market Restraints
Table 18. Global Coagulation Factors Market Opportunities
Table 19. Global Coagulation Factors Market Challenges
Table 20. Key Manufacturers Coagulation Factors Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Coagulation Factors Market Size, 2019 (K Units) & (US$ Million)
Table 22. Coagulation Factors Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Coagulation Factors Manufacturing Plants
Table 24. Key Manufacturers Coagulation Factors Market Served
Table 25. Date of Key Manufacturers Enter into Coagulation Factors Market
Table 26. Key Manufacturers Coagulation Factors Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Coagulation Factors Market Size by Type, 2020, (US$ Million)
Table 29. Global Coagulation Factors Market Size by Type, 2020 (K Units)
Table 30. Global Coagulation Factors Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Coagulation Factors Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Coagulation Factors Market Size by Application, 2020-2021 (K Units)
Table 33. Global Coagulation Factors Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Coagulation Factors Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Coagulation Factors Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Coagulation Factors Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Coagulation Factors Market Size, 2019-2021 (K Units)
Table 38. US Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Coagulation Factors Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Coagulation Factors Market Size, 2019-2021 (K Units)
Table 43. Germany Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Coagulation Factors Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Coagulation Factors Market Size, 2019-2021 (K Units)
Table 50. China Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Coagulation Factors Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Shire (Baxter) Business Overview
Table 58. Shire (Baxter) Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Shire (Baxter) Coagulation Factors Product
Table 60. Shire (Baxter) Response to COVID-19 and Related Developments
Table 61. Bayer Business Overview
Table 62. Bayer Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Bayer Coagulation Factors Product
Table 64. Bayer Response to COVID-19 and Related Developments
Table 65. CSL Business Overview
Table 66. CSL Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. CSL Coagulation Factors Product
Table 68. CSL Response to COVID-19 and Related Developments
Table 69. Pfizer Business Overview
Table 70. Pfizer Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Pfizer Coagulation Factors Product
Table 72. Pfizer Response to COVID-19 and Related Developments
Table 73. Grifols Business Overview
Table 74. Grifols Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Grifols Coagulation Factors Product
Table 76. Grifols Response to COVID-19 and Related Developments
Table 77. Biogen Business Overview
Table 78. Biogen Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Biogen Coagulation Factors Product
Table 80. Biogen Response to COVID-19 and Related Developments
Table 81. Octapharma Business Overview
Table 82. Octapharma Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Octapharma Coagulation Factors Product
Table 84. Octapharma Response to COVID-19 and Related Developments
Table 85. NovoNordisk Business Overview
Table 86. NovoNordisk Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. NovoNordisk Coagulation Factors Product
Table 88. NovoNordisk Response to COVID-19 and Related Developments
Table 89. Greencross Business Overview
Table 90. Greencross Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Greencross Coagulation Factors Product
Table 92. Greencross Response to COVID-19 and Related Developments
Table 93. Kedrion Business Overview
Table 94. Kedrion Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Kedrion Coagulation Factors Product
Table 96. Kedrion Response to COVID-19 and Related Developments
Table 97. BPL Business Overview
Table 98. BPL Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. BPL Coagulation Factors Product
Table 100. BPL Response to COVID-19 and Related Developments
Table 101. Hualan Bio Business Overview
Table 102. Hualan Bio Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Hualan Bio Coagulation Factors Product
Table 104. Hualan Bio Response to COVID-19 and Related Developments
Table 105. RAAS Business Overview
Table 106. RAAS Coagulation Factors Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. RAAS Coagulation Factors Product
Table 108. RAAS Response to COVID-19 and Related Developments
Table 109. Coagulation Factors Distributors List
Table 110. Coagulation Factors Customers List
Table 111. Covid-19 Impact on Coagulation Factors Customers
List of FiguresFigure 1. Coagulation Factors Product Picture
Figure 2. Coagulation Factors Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Coagulation Factors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Coagulation Factors Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Coagulation Factors Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Coagulation Factors Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Coagulation Factors Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Coagulation Factors Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Coagulation Factors Market Size Market Share, 2019-2021